These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25218988)

  • 1. The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice.
    Almeida-Santos AF; Gobira PH; Souza DP; Ferreira RC; Romero TR; Duarte ID; Aguiar DC; Moreira FA
    Eur J Pharmacol; 2014 Nov; 742():139-44. PubMed ID: 25218988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    Leite JV; Guimarães FS; Moreira FA
    Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aripiprazole, an atypical antipsychotic, on the motor alterations induced by acute ethanol administration in mice.
    Viana TG; Almeida-Santos AF; Aguiar DC; Moreira FA
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):319-24. PubMed ID: 23157340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.
    Narita M; Takei D; Shiokawa M; Tsurukawa Y; Matsushima Y; Nakamura A; Takagi S; Asato M; Ikegami D; Narita M; Amano T; Niikura K; Hashimoto K; Kuzumaki N; Suzuki T
    Eur J Pharmacol; 2008 Dec; 600(1-3):105-9. PubMed ID: 18955042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety.
    Biojone C; Casarotto PC; Resstel LB; Zangrossi H; Guimarães FS; Moreira FA
    J Psychopharmacol; 2011 Jun; 25(6):801-7. PubMed ID: 20699351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study.
    Marinho EA; Oliveira-Lima AJ; Wuo-Silva R; Santos R; Baldaia MA; Hollais AW; Longo BM; Berro LF; Frussa-Filho R
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):613-23. PubMed ID: 24345415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.
    Mavrikaki M; Nomikos GG; Panagis G
    Int J Neuropsychopharmacol; 2010 May; 13(4):541-8. PubMed ID: 20047715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole attenuates established behavioral sensitization induced by methamphetamine.
    Futamura T; Akiyama S; Sugino H; Forbes A; McQuade RD; Kikuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1115-9. PubMed ID: 20561555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned Reward of Opioids, but not Psychostimulants, is Impaired in GABA-A Receptor δ Subunit Knockout Mice.
    Siivonen MS; de Miguel E; Aaltio J; Manner AK; Vahermo M; Yli-Kauhaluoma J; Linden AM; Aitta-Aho T; Korpi ER
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):558-566. PubMed ID: 29781560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole blocks reinstatement but not expression of morphine conditioned place preference in rats.
    Li SX; Zou Y; Liu LJ; Wu P; Lu L
    Pharmacol Biochem Behav; 2009 Apr; 92(2):370-5. PubMed ID: 19353810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
    Oshibuchi H; Inada K; Sugawara H; Ishigooka J
    Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum.
    Batista LA; Viana TG; Silveira VT; Aguiar DC; Moreira FA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):11-6. PubMed ID: 26319049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of exogenous CCK-8 on the acquisition and expression of morphine-induced CPP.
    Wen D; Cong B; Ma C; Yang S; Yu H; Ni Z; Li S
    Neurosci Lett; 2012 Feb; 510(1):24-8. PubMed ID: 22245440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive administration of aripiprazole enhances locomotor response to methamphetamine in mice.
    Cheng MC; Hsu SH; Chen CH
    Behav Brain Res; 2011 Jan; 216(2):621-5. PubMed ID: 20833207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice.
    Jerlhag E
    Alcohol; 2008 Mar; 42(2):123-7. PubMed ID: 18358991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.
    Sørensen G; Sager TN; Petersen JH; Brennum LT; Thøgersen P; Hee Bengtsen C; Thomsen M; Wörtwein G; Fink-Jensen A; Woldbye DP
    Psychopharmacology (Berl); 2008 Jul; 199(1):37-46. PubMed ID: 18481046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphine.
    Torigoe K; Mori T; Shibasaki M; Yoshizawa K; Narita M; Suzuki T
    Synapse; 2012 Feb; 66(2):174-9. PubMed ID: 22033980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptors in the basolateral amygdala are involved in the potentiation of morphine rewarding properties in the acquisition, but not expression of conditioned place preference in rats.
    Haghparast A; Shamsizadeh A; Samandari R; Omranifard A; Vaziri A; Razavi Y
    Brain Res; 2014 May; 1565():28-36. PubMed ID: 24721524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.